Mirae Asset Global Investments’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,198
Closed -$443K 2666
2022
Q3
$443K Buy
22,198
+11,281
+103% +$149K ﹤0.01% 1945
2022
Q2
$75K Buy
+10,917
New +$76.6K ﹤0.01% 2346

Mirae Asset Global Investments's FMTX Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 22,198 shares — an estimated $443K sold.

Mirae Asset Global Investments first reported a position in FMTX in Q2 2022 and held it in 2 quarters. The position peaked at $443K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 22,198 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $443K.
  • Mirae Asset Global Investments first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Mirae Asset Global Investments's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $443K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.